CRC patients before therapy presented a higher MCM3AP-AS1 level than healthy individuals at admission (P < 0.05, Figure 1(a)), indicating that MCM3AP-AS1 is highly expressed in CRC. This evidence concerns the gene MCM3AP and colorectal carcinoma.